ASCO 2023: IDH mutation and improved cognitive functions in brain tumor patients June 4, 2023 by Alexandra Hartman Editor-in-Chief 2023-06-04 12:19:42 – ASCO 2023 ASCO 2023 Patients with this tumor with the IDH 1 and 2 mutation improve their motor and cognitive functions, in addition to avoiding long-term relapses. Grade 2 gliomas with a mutation in the IDH gene are malignant brain tumors that cause considerable morbidity and premature death. 1685882522 #Vorasidenib #stops #grade #glioma #surgery #delays #chemo #radium Share this: Share on Facebook (Opens in new window) Facebook Share on X (Opens in new window) X Alexandra Hartman Editor-in-Chief Editor-in-Chief Prize-winning journalist with over 20 years of international news experience. Alexandra leads the editorial team, ensuring every story meets the highest standards of accuracy and journalistic integrity.
